Comparative Study of LoKomat® Exoskeleton VS C-Mill® Treadmill for Gait Recovery in Rehabilitation.

Launched by UNIVERSIDAD CATÓLICA DE ÁVILA · May 6, 2025

Keywords

ClinConnect Summary

This clinical trial is comparing two types of robotic therapies, the LoKomat® exoskeleton and the C-Mill® treadmill, to see which one helps stroke patients recover their walking ability better. Both treatments aim to improve walking speed, balance, and overall quality of life for adults who have experienced a stroke. The study will look at how well these treatments work over a period of 12 weeks at the Lescer neurorehabilitation clinic in Madrid, Spain.

To participate in this trial, individuals need to have a stroke diagnosis and be mentally capable of understanding the treatment. They should be able to sign a consent form agreeing to participate. Unfortunately, people with severe cognitive impairment or other serious health issues that affect walking won't be eligible. Participants can expect to be evaluated at the beginning of the study and then again at 4, 8, and 12 weeks to see how their walking and overall well-being improve with either treatment. This study is still in the planning stages and has not started recruiting participants yet.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of stroke (haemorrhagic and/or ischaemic) by a specialist physician. specialist.
• • Subjects who are cognitively capable and who sign the informed consent form.
• Exclusion Criteria:
• • Severe cognitive impairment (Mini-Mental State Examination \< 24.), or impairment that prevents correct understanding of the correct understanding of the messages and explanatory orders of the treatment and its conditions.
• • conditions.
• • Diagnosis of concomitant neurological diseases and craniocerebral trauma. cranioencephalic trauma.
• • Other diseases that interfere with the gait process (e.g. disabling arthritis or arthrosis, other neurological diseases, other neurological diseases).
• • disabling arthritis or osteoarthritis, other concomitant neurological diseases, etc.).
• • - Contraindications of the robotic tools themselves.